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Summary 
During mitosis cells must segregate the replicated copies of their genome to their daughter cells 
with extremely high fidelity. Segregation errors lead to an abnormal chromosome number 
(aneuploidy), which typically results in disease or cell death [1].  Chromosome segregation and 
anaphase onset are initiated through the action of the multi-subunit E3 ubiquitin ligase known as 
the anaphase-promoting complex or cyclosome (APC/C [2]).  The APC/C is inhibited by the 
spindle checkpoint in the presence of kinetochore attachment defects [3, 4].  Here we 
demonstrate that two non-essential APC/C sub-units (Apc14 and Apc15) regulate association of 
spindle checkpoint proteins, in the form of the mitotic checkpoint complex (MCC), with the 
APC/C.  apc14 mutants display increased MCC association with APC/C and are unable to 
silence the checkpoint efficiently. Conversely, apc15 mutants display reduced association 
between MCC and APC/C, are defective in poly-ubiquitination of Cdc20 and are checkpoint 
defective.  In vitro reconstitution studies have shown that human MCC-APC/C can contain two 
molecules of Cdc20 [5-7].  Using a yeast strain expressing two Cdc20 genes with different 
epitope-tags, we show by co-immunopreciptation that this is true in vivo.  MCC binding to the 
second molecule of Cdc20 is mediated via the C-terminal KEN box in Mad3.  Somewhat 
surprisingly, complexes containing both molecules of Cdc20 accumulate in apc15 cells and the 
implications of this observation are discussed. 
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Results and Discussion 
Cdc20Slp1 (Slp1 is the fission yeast homologue of Cdc20) was identified several years ago as the 
key effector of the spindle checkpoint [8, 9], and the mitotic checkpoint complex (Cdc20-Mad3-
Mad2-Bub3) was found to be the most potent APC/C inhibitor [10].  The crystal structure of 
fission yeast MCC has been solved [11], and recently cryo-EM structures of human MCC in 
complex with APC/C were obtained from recombinant complexes produced in baculovirus-
infected insect cells [6, 7].  These models provide an excellent structural framework within which 
spindle checkpoint inhibition takes place, yet there are several areas requiring further insight.  
The Gould lab previously demonstrated that deletion of either the Apc14 or Apc15 sub-unit of 
fission yeast APC/C did not affect its ubiquitin ligase activity [12].  Apc14 is not well conserved, 
but in human and budding yeast cells it has been shown that there are spindle checkpoint 
silencing defects in the absence of Apc15 [13-15].  Therefore we analysed the fission yeast 
apc14 and apc15 strains for defects in checkpoint establishment, maintenance and/or 
silencing. 
 
apc15 mutants display spindle checkpoint defects 
First we employed the cold-sensitive beta-tubulin mutant nda3-KM311 to analyse the ability of 
cells to arrest in mitosis in the absence of spindle microtubules [16].  Fig. 1A demonstrates that 
whilst apc14 cells arrest like wild-type the apc15 cells display severe defects in this 
checkpoint assay.  We also analysed the ability of these apc mutants to arrest in response to 
Mad2 and Mps1Mph1 (Mph1 is the fission yeast homologue of Mps1 kinase) overexpression [17, 
18], and once again found that apc15 strains were significantly defective in arrest (Fig. 1B).  
The inability to respond to Mad2 overexpression places Apc15 function downstream in the 
spindle checkpoint pathway as the only other checkpoint protein required for the Mad2 
overexpression arrest is Mad3, the other key component of fission yeast MCC [19]. 
This suggested that Apc15 might have a role in MCC assembly and/or its association with the 
APC/C.  To test this we analysed MCC assembly in an unperturbed mitosis, having synchronised 
cells at G2-M using the cdc25-ts allele.  Fig. 1C shows that there is little effect on MCC assembly 
in the absence of either Apc14 or Apc15.  However, we note that in the apc15 mutant the levels 
of Cdc20Slp1 and the MCC complex are 2-3 fold higher and stay high for longer, even though they 
display no delay in anaphase (see Fig S1A-C). 
When we analysed the ability of the MCC complex to bind to the APC/C we saw striking effects 
in both apc14 and apc15 strains (Fig. 2A).  Cells were synchronised at G2-M and then 
released into mitosis. The levels of MCC bound to the APC/C in apc15 strains were reduced to 
a level similar to those in the absence of Mps1Mph1 kinase activity [20].  Conversely, the MCC 
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levels bound in apc14 strains were 2-3 fold higher than in wild-type cells (see Fig S2 for 
quantitation).  The simplest interpretation of these data is that Apc15 is required for stable MCC 
binding to APC/C, which is consistent with the checkpoint defects observed in apc15 strains 
(Fig 1), whereas Apc14 function is required for efficient MCC release and checkpoint silencing.   
 
apc14 mutants display checkpoint silencing defects 
To analyse the apc14 phenotype in more detail, we employed a checkpoint silencing assay that 
we previously developed during studies of protein phosphatase 1 [21].  Cells are arrested without 
microtubules using the nda3 mutation [16] and then Aurora activity is inhibited using the ark1-as3 
allele [22].  Because Ark1 activity is necessary to maintain spindle checkpoint arrests [21, 23] 
these cells rapidly degrade cyclin B.  Fig. 2B shows that there is a clear delay in cyclin B 
degradation in apc14 cells, consistent with the hypothesis that Apc14 has a role in checkpoint 
silencing.  This Apc14 silencing function is the subject of ongoing work, but was not analysed 
further in this study. 
 
Apc15 is cell cycle regulated 
Transcript data in PomBase [24] show that Apc15 expression is tightly cell cycle regulated with 
highest expression at G2/M.  Therefore we analysed the cell cycle levels of the Apc15 protein.  
Apc15 is a rather small protein and we were concerned that epitope tags might perturb its 
function.  Therefore we generated specific, polyclonal antibodies to Apc15.  Fig. S2B shows that 
the levels of Apc15 increase ~2-fold during mitosis and Fig. 2C demonstrates that Apc15 levels 
increase further during prolonged checkpoint arrest.  As is the case for many APC/C sub-units, 
Apc15-GFP accumulates in the nuclei of mitotic cells [25].  We carried out several experiments to 
test whether the Apc15 newly synthesised at G2/M is important for checkpoint function and 
whether Apc15 is itself subject to ubiquitin-mediated degradation.  As yet we have found no clear 
evidence that this regulation is physiologically important for mitosis (see Fig S2). 
At this point we had two simple hypotheses for Apc15 function:  1) Apc15p could act as a loading 
factor, by first binding to MCC and then helping it associate with the APC/C core particle, or 2) 
Apc15 might form an important part of the MCC docking site on the APC/C.  To distinguish 
between these modes of action, we analysed the association of Apc15 with the APC/C and with 
MCC proteins in yeast lysates.  To test whether there was a free pool of Apc15p and if this could 
interact with the MCC, we carried out immunodepletion of Apc1-GFP from mitotic extracts.  As 
expected, Apc15 co-immunoprecipitates with Apc1-GFP (Fig. 2D).  No Apc15 remains 
associated with Apc1-GFP in an extract after three rounds of Apc1-GFP immunodepletion, yet 
there is still a significant pool of free Apc15.  Importantly, when we immunoprecipitated this free 
pool of Apc15 it was not associated with Mad3, Mad2 or Cdc20 (Fig. 2D).  This experiment 
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indicates that whilst there was a significant non-APC/C bound pool of Apc15, it was not 
associated with the MCC complex or proteins therein.  This argues against the model where 
Apc15 acts as an MCC loading factor, as it would be expected to bind MCC components 
independently of APC/C binding.  The role of the free Apc15 pool remains unclear, but its 
existence likely explains why there was no significant phenotype upon transcriptional depletion of 
Apc15 (Fig. S2D-F). 
 
Fission Yeast Apc15 is required for efficient Cdc20 ubiquitination  
Deletion of Apc15 had no effect on the ability of cells to assemble the MCC, but we noted that 
the levels of Cdc20 and MCC remained high for longer in apc15 than in wild type cells (Fig 1C).  
This suggested that Apc15 might regulate Cdc20 protein levels and that it could be required for 
efficient Cdc20 ubiquitination and/or degradation. To determine if this was the case we arrested 
cells in metaphase using mts3-1 [26], a proteasome mutant that does not require a functional 
checkpoint for arrest, then immunoprecipitated Cdc20-FLAG. It was hoped that the mts3-1 
mutation would stabilise ubiquitin-modified forms of Cdc20, due to defective proteasome action.  
When we probed immunoblots for Cdc20 we could now detect a discrete ladder of slower 
migrating bands (Fig. 3A&B).  Addition of phosphatase had no effect on these bands, but the 
ladder was removed in extracts treated with the recombinant deubiquitinase USP2 [27].  This 
demonstrates that Cdc20 accumulates in polyubiquitinated forms in these mitotically arrested 
mts3 cells.  Poly-ubiquitination of Cdc20 is dependent on MCC formation [28, 29].  As expected, 
in mad3 and mad2 strains which are unable to form MCC Cdc20 ubiquitination was largely 
abolished.  Importantly, in apc15 cells Cdc20 was still ubiquitinated, but there was an 
accumulation of Cdc20 molecules with shorter (~1-4) Ub chains (Fig. 3B). This suggests that in 
fission yeast deleting Apc15 does not block the initial binding of MCC to the APC/C and the 
subsequent ubiquitination of Cdc20, but that Apc15 is required for processive ubiquitination of 
Cdc20.  This is consistent with our observation that less MCC binds to APC/C in apc15 cells 
(Fig. 2A).  We propose that MCC frequently ‘falls off’ an APC/C particle lacking Apc15 before 
longer chains of ubiquitin can be added to Cdc20, leading to reduced processivity of Cdc20 
ubiquitination.  As a consequence, the Cdc20 protein is stabilised in apc15 cells and free MCC 
levels accumulate (see Fig S1A&B). 
Further analysis shows that mad3-ken2 mutants also displayed reduced ubiquitination, and that 
the mad3-ken2 apc15 double mutant is completely unable to poly-ubiquitinate Cdc20 (Fig. 3A).  
This suggests that Mad3-KEN2 and Apc15 are both involved in stabilising key MCC-APC/C 
interactions in fission yeast that are required for efficient Cdc20 ubiquitination and for checkpoint 
arrest.  This agrees well with the accompanying manuscript where KEN2 and its conserved 
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flanking ABBA motifs are all shown to enhance Cdc20-APC/C inhibition and spindle checkpoint 
arrest [30]. 
 
Fission yeast MCC can contain two Cdc20 molecules and binding of the second molecule 
is Mad3-KEN2 but not Apc15-dependent 
Musacchio and co-workers proposed several years ago that a second molecule of Cdc20 in 
MCC complexes would help explain the need for two conserved KEN boxes in Mad3/BubR1 and 
aspects of Cdc20 turnover [2, 29].  It was then argued from in vitro studies that human MCC can 
bind a second molecule of Cdc20, enabling it to inhibit active Cdc20-APC/C [5].  Recent cryo-EM 
studies have demonstrated that when human MCC-APC/C is reconstituted in insect cells there 
are indeed MCC complexes that contain two Cdc20 molecules [6, 7].  To distinguish the two 
Cdc20 molecules, we will refer to them as the MCC bound form (Cdc20M) and the APC/C-bound 
or activator form (Cdc20A). 
To provide formal proof of the second Cdc20 molecule in a living system, we generated a fission 
yeast strain containing a second copy of the Cdc20Slp1 gene.  This copy has an internal 3xFLAG 
tag [31], enabling it to be readily distinguished from the first copy which has a C-terminal 3xHA 
tag.  Both of these forms of Cdc20Slp1 are functional and bind APC/C (see below).  If two copies 
of Cdc20 are present in the MCC then the two proteins would be co-immunoprecipitated from 
mitotic extracts.  Fig. 3B shows that this is the case, that their interaction is dependent on 
Mad3p, and importantly that their interaction is dependent on both of the conserved Mad3-KEN 
boxes.  The first KEN box (KEN1) is known to be critical for direct Cdc20 binding and MCC 
formation [11], but the function of the second KEN box (KEN2) is less well understood [32].  
KEN2 is widely recognised as being necessary for checkpoint function, but not for MCC 
formation.  In BubR1, it can compete with substrates for APC/C interaction in vitro [32].  Our 
findings that Mad3-KEN2 is needed for interaction with the second molecule of Cdc20 is in 
agreement with the human study where the D-box and the second KEN box in BubR1 were both 
found to be necessary [5], and with the recent cryo-EM structures [6, 7].  Importantly, our Cdc20-
Cdc20 co-immunoprecipitation experiment is carried out in whole cell extracts made from mitotic 
fission yeast cells.  Our findings are confirmed in the accompanying fission yeast manuscript 
[30], where two forms of Cdc20 (one tagged and one un-tagged) are shown to interact in mitosis.  
One way to form these Cdc20-Cdc20 complexes would be for the MCC as a whole to form 
dimers, either simply with itself or on a larger platform.  In this model, all members of the MCC 
complex would contain two molecules, rather than just Cdc20.  To test this we engineered fission 
yeast strains expressing normal Mad3 and Mad3-GFP, and asked whether the two forms of 
Mad3 can be co-immunoprecipitated in mitotically arrested cells. Figure S3B shows that this was 
not the case, ruling out MCC dimerisation. 
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The model proposed in the human studies [5] was that MCC (Cdc20M-Mad3-Mad2) binds and 
inhibits an active Cdc20A-APC/C complex to form Cdc20M-Mad3-Mad2-Cdc20A-APC/C 
(containing two Cdc20 molecules).  Our apc15 mutant allowed us to test this model in fission 
yeast.  If this were the case, one would predict that the apc15 mutant, which impairs the 
interaction between MCC and APC/C, will reduce or abolish the interaction between the two 
Cdc20 molecules.  Fig. 3B shows that this is not the case as efficient co-immunoprecipitation of 
Cdc20-FLAG and Cdc20-HA was still observed in apc15 cells, indeed these complexes 
accumulated in the mutant (see also Fig. S3A).  Fig. 2A demonstrates that there was a 
significant reduction in the level of MCC bound to APC/C in apc15 mutants, yet Fig. 3B reveals 
complexes containing multiple Cdc20 molecules.  To confirm that these Cdc20 complexes were 
not associated with APC/C, we depleted APC/C from apc15 extracts via four rounds of Cut9-
GFP immunodepletion and asked whether the free pool of MCC still contains two molecules of 
Cdc20 (Cdc20-HA -Mad3-Mad2- Cdc20-FLAG).  Fig. 4A shows that this is the case and that 
there is significantly more of this complex in apc15 mutant extracts compared to wild-type.  We 
note that this observation is not necessarily in line with the proposed human model of Cdc20-
APC/C inhibition [5] and we suggest two models to explain our fission yeast observations: 
a) Apc15 forms an important part of the MCC binding site on APC/C.  As a consequence, in 
apc15 cells the MCC (Cdc20M-Mad3-Mad2) might preferentially bind to free Cdc20 rather than 
Cdc20A-APC/C complexes.  This will sequester Cdc20 and form a free pool of Cdc20M-Mad3-
Mad2-Cdc20A.  Such sequestration may well help inhibit Cdc20 action, and the accompanying 
manuscript [30] shows this to be the case when Cdc20 levels are reduced.  However, we note 
that the Cdc20M in these complexes would not be ubiquitinated unless the complex then bound 
to APC/C. 
b) MCC binds to Cdc20A-APC/C, but their interaction is weakened in the absence of Apc15 and 
the MCC-Cdc20A-APC/C complex is rather short-lived.  A consequence of this brief interaction 
with the APC/C is that it would lead to a reduced processivity of Cdc20M ubiquitination in 
apc15cells.  This is consistent with the short Ub-chains we have observed on Cdc20 in apc15 
(Fig. 3B).  Importantly, when the MCC complex dissociates it takes the Cdc20A activator with it  
to form free Cdc20M-Mad3-Mad2-Cdc20A.  
NB. These models are not mutually exclusive.  It is important to include the free Cdc20M-Mad3-
Mad2-Cdc20A complex in overviews of MCC action and Cdc20 inhibition (see Fig. 4B). 
 
Conclusion 
At first glance, fission yeast Apc15 appears to have a simple role to play in helping the MCC 
stably bind to the APC/C core particle and this is consistent with its position in recent high-
resolution cryo-EM structures of the APC/C.  Budding yeast and in vitro human studies argued 
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that Apc15 is needed for efficient Cdc20 ubiquitination and subsequent MCC release [13, 15].  
Based on the cryo-EM models, it was proposed that human Apc15 undergoes a conformational 
change to shift MCC into a suitable orientation for Cdc20 auto-ubiquitination [6] [7].  Our study is 
consistent with this, as Cdc20Slp1 displays reduced ubiquitination and is stabilised in fission yeast 
apc15 cells (Fig. 3A).  However, fission yeast Apc15 is also needed for stable MCC binding and 
thus for spindle checkpoint arrest, which is not the case in human and budding yeast cells. 
 
Importantly we also provide in vivo evidence for complexes containing two Cdc20 molecules in 
fission yeast.  Interaction with the second molecule of Cdc20 is mediated by the C-terminus of 
Mad3, including its second KEN box and the nearby ABBA motifs [32-34].  Our work and the 
accompanying manuscript [30] both describe in vivo fission yeast studies which provide an 
important confirmation of models proposed from in vitro reconstitution studies of human MCC 
proteins and their interactions with APC/C.  New findings are presented here where, 
paradoxically, whilst apc15 mutants display reduced levels of MCC bound to the APC/C (Fig. 
2A) they also accumulate Cdc20-Cdc20 complexes (Fig. 3B).  We have suggested two models 
to generate the free pool of Cdc20M-Mad3-Mad2-Cdc20A that we observe in apc15 mutants 
(see Fig. 4B).   
 
In fission yeast we find that deletion of Apc14 leads to checkpoint silencing defects. In its 
absence there are higher than normal levels of MCC bound to the APC/C, and experiments are 
ongoing to understand its mode of action.  It will be interesting to see if in the absence of Apc14 
the MCC simply binds more tightly to APC/C, or whether Apc14 has an active role similar to 
p31comet (not conserved in S.pombe), TRIP13 or the CCT chaperone in disrupting MCC-APC/C 
complexes [35, 36]. 
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Experimental Procedures 
See the Supplemental Experimental Procedures. 
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Figure legends 
 
Figure 1.  apc15 mutants are checkpoint defective. 
(A) Checkpoint arrest:  nda3 strains were grown to log phase and then shifted to 18oC to de-
polymerise microtubules and thereby activate the spindle checkpoint.  At the time points 
indicated, cells were fixed in methanol and the mitotic index scored by analysing the levels and 
localisation of Cdc13-GFP (cyclin B).  Cdc13-GFP localises to the spindle pole bodies in early 
mitosis. The apc14 mutant arrests proficiently, but apc15 and mad2 mutants do not.  This 
experiment was repeated 3 times (with at least 100 cells scored per strain at each time point) 
and the data is plotted as the mean +/- SD. 
(B) Mad2 and Mph1 overexpression:  cultures containing plasmids expressing Mad2 from the 
nmt1 promoter or Mph1 from the nmt41 promoter were induced (- thiamine) for 18 hours and the 
mitotic index scored by immunostaining of microtubules and spindle length. This experiment was 
repeated 2 times (with at least 100 cells scored per strain at each time point) and the data is 
plotted as the mean +/- SD. 
(C) MCC assembly is not affected.  cdc25-22 cdc20-FLAG cultures were synchronised at G2/M 
by cdc25 block and release, cell samples taken at 15 minute intervals, Cdc20 
immunoprecipitated and analysed for associated checkpoint proteins (Mad3 and Mad2).  This 
experiment was repeated 3 times and a representative example is shown here. 
See also Figure S1. 
 
 
Figure 2.  apc14 and apc15 mutants both perturb the interaction between MCC 
complexes and the APC/C, but in opposite ways. 
(A) APC/C binding time courses:  cdc25-22 apc4-TAP mad3-GFP cultures were synchronised at 
G2/M by cdc25 block and release, cell samples taken at 15 minute intervals, Apc4-TAP pulled 
down and analysed for associated checkpoint proteins (Mad3 and Mad2).  The cells from each 
time point were fixed in methanol and the number of binucleate cells determined by DAPI 
staining DNA. This experiment was repeated 2 times and a representative example is shown 
here. 
(B) Checkpoint silencing assay.  nda3KM-311 cdc13-GFP strains were arrested by shifting to 
18oC to de-polymerise microtubules and thereby activate the spindle checkpoint.  The Ark1-as 
kinase was then inhibited with 5M 1NM-PP1 and live cell samples analysed at 15 minute 
intervals. Ark1 inhibition activates the APC and Cdc13-GFP is rapidly degraded in wild-type cells.  
The mitotic index was scored in live cells by analysing the levels and localisation of Cdc13-GFP 
(cyclin B).  In arrested cells this is nuclear with a bright signal at the SPBs.  The number of cells 
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that degrade Cdc13-GFP is shown as a percentage of arrested cells at t=0. This experiment was 
repeated at least 3 times (with at least 100 cells scored per strain at each time point) and the 
data is plotted as the mean +/- SD. 
(C)  nda3-KM311 mutants were grown to log phase and then shifted to 18oC for 6 hours, taking 
time points at 2 hour intervals. Whole cell immunoblots were then analysed for levels of Apc15 
Mad3 and tubulin. This experiment was repeated 3 times and the data is plotted as the mean +/- 
SD.  See Figure S2B for quantitation of Apc15 levels through the cell cycle. 
(D) Cells were synchronised in mitosis (60 mins post cdc25 block & release), lysates prepared 
and then immunodepleted for APC/C complexes through four rounds of Apc4-GFP immuno-
precipitation.  Apc15 was then immunoprecipitated from the final supernatant.  The five sets of 
beads were then analysed for associated Cdc20 and checkpoint proteins, revealing high levels 
of free Apc15 post-APC/C depletion. This experiment was repeated 2 times. 
See also Figure S2. 
 
Figure 3.  apc15 mutants have significant defects in the processivity of Cdc20Slp1 
ubiquitination and fission yeast MCC-Cdc20-APC/C contains two molecules of Cdc20 
(A) Cdc20 ubiquitination experiments.  The indicated strains all contain the mts3-1 proteasome 
mutation, to block cells in mitosis independently of the spindle checkpoint and to enrich for poly-
ubiquitinated forms of cellular proteins.  Cultures were shifted to 36oC three hours prior to 
harvesting.  Whole cell lysates were made in the presence of Dub inhibitors and Cdc20-FLAG 
was immunoprecipitated, then immunoblotted for Cdc20-FLAG.  Long exposure reveals a ladder 
of slow migrating bands, which are reduced in mad3 and apc15 mutants. The indicated lysates 
were treated with recombinant hsUSP2 (deubiquitinase) or lambda phosphatase prior to running 
the gel. Lambda phosphatase has no effect, but USP2 abolishes the ladder confirming that this 
is due to modification with Ubiquitin.  Different modified forms of Cdc20 accumulate in the mts3 
and apc15 mts3 mutants, with shorter chains in the absence of Apc15.  These are indicated 
with green and red markings by the relevant anti-ubiquitin blots. 
This experiment was repeated 3 times. 
(B) The indicated lanes from panel (A) are expanded to highlight the different modified forms of 
Cdc20 that accumulate in the mts3, apc15mts3 and apc14mts3 mutants.  Most notably there 
are shorter chains in the absence of Apc15 (boxed in red). 
(C) Cdc20-FLAG and Cdc20-HA co-immunoprecipitate.  Cells containing both Cdc20 forms were 
synchronised in mitosis (60 mins post cdc25 block & release), lysates prepared and Cdc20-
FLAG was immunoprecipitated.  The immunoprecipitates were then immunoblotted and 
analysed for associated Cdc20-HA, Mad3-GFP, Mad2 and Apc15. * indicates Cdc20-Cdc20 co-
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immunoprecipitation.  This experiment was repeated 3 times.  The % of metaphase cells is 
indicated below the blot for the six strains. 
See also Figure S3. 
 
Figure 4.  A free pool of Cdc20M-Mad3-Mad2-Cdc20A accumulates in apc15 mutants. 
(A) The MCC (Cdc20M-Mad3-Mad2) - Cdc20A complex can be found in the APC/C-depleted 
supernatant and the complex accumulates in apc15.  Mitotic lysates were prepared from cdc25-
22 cdc20-HA cdc20-FLAG Apc6Cut9-GFP (60 mins post cdc25 block & release) and then 
immunodepleted for APC/C complexes through four rounds of cut9apc6-GFP immunodepletion.  
Cdc20-FLAG was then immunoprecipitated from the resulting supernatant and immunoblotted to 
look for associated Cdc20-HA and checkpoint proteins.  The MCC (Cdc20M-Mad3-Mad2) - 
Cdc20A is immunoprecipitated without Apc6Cut9-GFP or Apc15.  This experiment was repeated 2 
times. 
(B) Models of MCC binding and Cdc20 ubiquitination, in wild-type cells and apc15 mutants. (i) 
When the checkpoint is on, MCC binds to Cdc20-APC/C and in fission yeast this interaction is 
stabilised by Apc15.  The C-terminus of Mad3 (KEN2 and associated ABBA motifs) is critical for 
this stable interaction with the second molecule of Cdc20 (Cdc20A).  (iia) In apc15 cells the 
MCC could preferentially bind free Cdc20A.  (iib) In the absence of Apc15 the MCC complex is 
weakly bound and Cdc20M inefficiently ubiquitinated.  It is released with short ubiquitin chains in 
the form of Cdc20M-Mad3-Mad2-Cdc20A.  Note that both molecules of Cdc20 are released from 
the APC/C. (iii) In wild-type cells Cdc20M is efficiently poly-ubiquitinated, leading to its 
degradation.  Apc14 function is required for efficient release of MCC. (iv) The checkpoint is off:  
APC/C is now free to be bound by Cdc20A activator, which can catalyse the poly-ubiquitination of 
securin and cyclin leading to anaphase onset. 
See also Figure S4.  
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Figure S1, related to Figure 1C 
(A) cdc25 strains containing wild-type, apc14Δ, apc15Δ and mph1-kd were synchronised in G2 then released in 
mitosis. Progression through mitosis was monitored by scoring the number of binucleate cells.  This shows that 
the majority of cells in Figure 1C had entered anaphase by 90mins. 
(B) Cdc20 levels are increased in apc15Δ.  The levels of Cdc20 in lysates from Figure 1C were quantitated and 
normalised for loading. The plot shows the amount of Cdc20, relative to the level in wild-type, at the time points 
when Cdc20 levels peaked in each mutant. Plotted as mean with standard deviation (n = 3 experiments). 
(C) MCC levels are increased in apc15Δ. The levels of the MCC subunit Mad2 in immunoprecipitations from 
Figure 1C were quantitated and normalised against immunoprecipitated Cdc20 levels.  The plot shows the 
amount of Mad2 relative to the level in wild-type at the time points when Cdc20 levels peaked in each mutant. 
Plotted as mean with standard deviation (n = 3 experiments). 
 
Figure S2, related to Figure 2 
(A) cdc25 strains along with those containing apc14Δ, apc15Δ or mph1-kd were synchronised in G2 then 
released into mitosis. Progression through mitosis was monitored by scoring the number of binucleate cells.  
This data shows that the majority of cells in Figure 2A had entered anaphase by 75mins, and had completed 
mitosis by 120mins. 
(B) Quantitation of MCC levels bound to APC/C.  The levels plotted for the 3 strains are the combined levels of 
bound Mad3 and Mad2, relative to wild-type levels (set at 1.0), at the three time points indicated after cdc25 
block/release.  This experiment was repeated twice and data is plotted as the mean +/- SD. 
(C) Apc15 levels increase in mitosis.  Cultures were synchronised at G2/M by cdc25 block and release, cell 
samples taken at 15 minute intervals and immunoblots analysed for levels of Apc15 and Mad2 as a loading 
control. This experiment was repeated 4 times and a representative example is shown here. The fold increase of 
Apc15 levels is shown for each time point and the data is plotted as the mean +/- SD.  Previous work has shown 
that whilst the abundance of several APC/C sub-units remain constant through the cell cycle (e.g. Nuc2 and 
Cut9 [S1]) others (eg. Cut23 [S2]) also increase in mitosis. 
(D) Apc15 'switch OFF' experimental scheme. nda3-KM11 cells with apc15 under the control of the inducible 
nmt81 promoter were grown in minimal media with (Apc15 OFF) or without (Apc15 ON) thiamine. To 'switch 
off' Apc15 expression the Apc15 ON culture was split into 2 flasks and thiamine added to one of the flasks 
(Apc15 Switch OFF), then all were incubated for 2hrs at 30oC before shifting their temperature to 17.5oC to 
induce mitotic arrest. Samples were taken every 2hrs and processed for protein extraction and microscopy. 
(E) Mitotic expression of Apc15 is not required for checkpoint arrest. The nda3 mutant Apc15 ON, Apc15 OFF 
and Apc15 'switch off' cultures (as described in S3C), along with apc15+ and apc15Δ controls, were shifted to 
17.5oC to induce mitotic arrest. Their ability to arrest was determined by cdc13-GFP localisation (this cyclin B 
accumulates in nuclei and at spindle poles in arrested cells).  apc15Δ and Apc15 OFF did not arrest, but the 
Apc15 'switch' OFF strain was able to arrest as well as Apc15 ON and apc15+ expressed from the endogenous 
promoter. 
(F) Protein extracts from the cells in Figure S3D were prepared and Apc15 levels analysed by immunoblotting 
(anti-Apc15). No Apc15 was detected in Apc15 OFF (* indicates a non-specific band recognised by the anti-
Apc15 antibody). Importantly, the Apc15 levels in Apc15 ON were comparable to levels expressed from the 
endogenous promoter and the Apc15 levels had decreased 2 hrs after expression was repressed (Switch OFF) 
and thus before the checkpoint was activated using the nda3 mutant. 
 
Figure S3, related to Figure 3B 
(A) Cdc20-FLAG and Cdc20-HA co-immunoprecipitate (related to Figure 4A).  Cells containing both Cdc20 
forms were synchronised in mitosis (60 mins post cdc25 block & release), lysates prepared and Cdc20-FLAG or 
Cdc20-HA was immunoprecipitated.  The immunoprecipitates were then immunoblotted and analysed for 
associated Cdc20-HA (or Cdc20-FLAG), Mad3-GFP, Mad2 and Apc15. The second Cdc20 form is associated 
with each immunoprecipitated Cdc20, and mad3 mutants abolish this interaction. Importantly, the interaction 
with between two Cdc20 molecules is dependent on KEN2, as well as KEN1.  It is not dependent on Apc15.  
This experiment was repeated 3 times. 
(B) Mad3 and Mad3-GFP do not co-immunoprecipitate.  Cells expressing both Mad3 forms were synchronised 
in mitosis (60 mins post cdc25 block & release), lysates prepared and Mad3-GFP was immunoprecipitated.  No 
untagged Mad3 protein was detectable in these IPs.  This argues against the presence of MCC dimers. 
 
 
Figure S4, related to Figure 4A 
 
(A) Mitotic lysates from Figure 4A.  These were immunoblotted for the indicated proteins, with tubulin being 
used as a loading control. 
 
 
  
 
  
Supplemental Experimental Procedures 
 
 
Deletion of apc14 and apc15  
To replace the entire open reading frame with NatR, KanR or HphR, the resistance cassettes were amplified 
from pFA6 vectors by PCR using compatible long primers [S3] with 5’ sequences homologous to the 5’ and 3’ 
UTRs of apc14 or apc15. Resulting PCR products were transformed [S4] into RA366 and the gene deletions 
confirmed by PCR. 
 
Mitotic arrests 
nda3-KM311(cs) cells were grown overnight in YES media at 30oC to mid-log phase then shifted to the 
restrictive temperature of 17.5oC. Cells were fixed in 100% ice cold methanol at each time point. For 
microscopy, cells were mounted with 20 µg/ml DAPI (Sigma) and visualized using an Intelligent Imaging 
Innovations Marianas microscope (Zeiss Axiovert 200M, using a 100x 1.3NA objective lens), CoolSnap CCD, 
and Slidebook software (Intelligent Imaging Innovations, Inc., Boulder, CO). 
 
Mph1 was overexpressed [S5] from the nmt41 promotor at the endogenous locus. To induce Mph1 expression 
cells were precultured in minimal medium with supplements (PMGS) and 15µM thiamine, cells were washed 3 
times in H20 to remove thiamine then grown in PMGS at 30oC for 18 hours before analysis. Mitotic arrest was 
determined by immunostaining microtubules with TAT1 antibody (kindly provided by Keith Gull, Oxford, UK). 
Mad2 was overexpressed from the multicopy pRep1-Mad2 in the same way [S6]. 
 
To synchronise cells in mitosis temperature sensitive (ts) cdc25-22 cells were grown overnight in YES medium 
at 25°C to mid-log phase and then shifted to 36°C for 3.5 hrs to arrest cells in G2. To release into mitosis, 
cultures were rapidly cooled down to 25°C in iced-water and then incubated at 25°C for the experimental time 
course. Progression through mitosis was monitored by DAPI staining and counting binucleate cells. 
 
Silencing Assay 
The silencing assay was carried out as in [S7]. Briefly, cells were arrested in metaphase using nda3-KM311 
grown at 17.5°C for 5.5hrs 5µM 1NM-PP1 was added and the degradation of Cdc13-GFP analysed by 
microscopy of live cells every 15mins. The number of cells degrading Cdc13-GFP was determined as a 
percentage of the number of metaphase arrested cells before 1NM-PP1 addition. 
 
Immunoprecipitations 
MCC (Cdc20Slp1-FLAG) immunoprecipitation 
Cells expressing Cdc20Slp1-FLAG [S8] were pre-synchronised in G2 by cdc25-22 arrest then release into 
mitosis. Harvested cells were pelleted at 4°C and snap frozen on dry ice. Proteins were extracted in lysis buffer 
(50 mM HEPES pH 7.5, 75 mM KCl, 1 mM MgCl2, 1 mM EGTA, 0.1% TritonX-100, 1 mM sodiumvanadate, 
0.1 µM microcystin, 10 µg/ml CLAAPE (chymostatin, leupeptin, aprotinin antipain pepstatin, E64) ‘mini 
complete EDTA-free protease inhibitor’ tablet (Roche) and 1 mM pefabloc). Cells were resuspended in lysis 
buffer and bead-beaten twice for 20 seconds. Extracts were incubated for 20 min with anti-FLAG (M2, Sigma) 
antibodies that had been pre-coupled to Dynabeads (Invitrogen). The immunoprecipitated complexes were 
washed three times with lysis buffer, twice in PBS and then analysed by immunoblotting with sheep anti-GFP 
antibody and sheep anti-Mad2 antibody. 
 
Anaphase promoting complex interaction 
Cells expressing TAP-tagged Lid1 (Apc4) (original strain kindly provided by Kathy Gould, Vanderbilt, USA) 
immunoprecipitated as above, but were incubated for 30 min with IgG-coupled Dynabeads (Invitrogen), which 
bind to Apc4-TAP. 
Blot quantitation  
Samples from all strains were collected on one day and then analysed the next day in parallel. Time course 
samples were processed at the same time and the full set of IPs were run on gels and transferred to membrane in 
parallel (whole cell lysates were typically run the following day). eg. Membrane organisation for Fig 1: wild-
type and apc14∆ IPs were on one membrane, mph1-KD and apc15∆ IPs on another. The input lysates were run 
and transferred to membranes as for the IPs. Note, for Fig1 the same membrane was first probed with anti-
FLAG (Cdc20Slp1) and anti-Mad2, then stripped and re-probed with anti-GFP (Mad3), so one pipetted IP sample 
was being analysed for all 3 proteins. For Fig2, anti-GFP antibody recognised lid1-TAP, Mad2-GFP and Mad3-
GFP. For each antibody all of the membranes were exposed at the same time to a single piece of film for each 
exposure.  
Immunoprecipitates from such time courses were analysed by ImageJ and corrected for loading (and normalized 
for the level of Cdc20Slp1 in the IP). 
 
For analysis of Cdc20Slp1-ubiquitin 
Cells were synchronised in mitosis as above and harvested 60 min after release from the G2/M block. Lysates 
were prepared as above with addition of 10mM MG132, 40mM PR-619 200mM 1,10-phenanthroline, 500mM 
iodoacetamide and 400mN NEM to the lysis buffer. 
  
Analysis of Cdc20Slp1- Cdc20Slp1complexes 
A second copy of Cdc20 was inserted in the genome by integrating cdc20Slp1-FLAG with 5’ and 3’ regulatory 
regions into the ura4 locus.  An 800bp cdc20+ promoter sequence and the cdc20-FLAG-hyg+ open reading 
frame (with 3’UTR sequences) was amplified by PCR and cloned to the Stu1 site of pBluescript-ura4+ by 
Gibson assembly reaction (Gibson et al., 2009). Endogenous cdc20Slp1 was HA tagged.  Cells were synchronised 
in mitosis and lysates prepared as above, then extracts were incubated for 20 min with anti-FLAG (M2, Sigma) 
or anti-HA (12CA5) antibodies that had been pre-coupled to Dynabeads (Invitrogen). 
 
APC depletions   
nda3-KM311 apc1-GFP cells were grown at 30°C in concentrated rich medium to high densities then arrested in 
mitosis by rapid cooling on iced-water and shifting cultures to 18°C for 8 hours. Cells were harvested by 
centrifugation at 3,500g for 8 minutes at 4°C. Pelleted cells were frozen into pea-sized drops using liquid 
nitrogen and stored at -80°C.  Approximately 15 g of cell mass was disrupted using a mixing mill (MM400; 
Retsch, Germany) with grinding balls under cryogenic conditions (5 cycles of 3 minutes at 30 Hz).  
 
Lysates were reconstituted with 2.5g of yeast powder and 5ml lysis buffer (50 mM HEPES pH 7.5, 75 mM KCl, 
1 mM MgCl2, 1 mM EGTA, 1 mM sodium vanadate, 0.1 µM microcystin, 10 µg/ml CLAAPE (chymostatin, 
leupeptin, aprotinin antipain pepstatin, E64), a ‘mini complete EDTA-free protease inhibitor’ tablet (Roche)  
and 1 mM Pefabloc).  Triton X100 (0.1% final) was added after lysates were resuspended. Following further 
lysis, by sonication, cell debris was pelleted at 14,000g for 15 min at 4°C and the supernatant was filtered 
through a 1.6 µm syringe filter. Cleared lysates were incubated with precoupled anti-GFP antibodies, that had 
been pre-coupled to Dynabeads (Invitrogen), for 30 min. The resulting supernatant was incubated with fresh 
GFP Dynabeads for 30min and Dynabeads with bound proteins were washed three times with lysis buffer before 
eluting proteins in 1x SDS sample buffer. This process was repeated 3 times, then the 4th supernatent was 
incubated with pre-coupled anti-Apc15 Dynabeads for 30 min at 4°C 
 
Apc6Cut9-GFP depletions were carried out as above except, cdc25-22 cut9-GFP cells were grown at 25°C, 
synchronised at G2/M, then cells were harvested 60min after release into mitosis. Lysates were prepared as for 
MCC immunoprecipitation by bead beating 0.2g cell pellets twice for 30 sec in lysis buffer with 0.1% TritonX-
100. Lysates were incubated for 15 min with anti-GFP antibodies that had been pre-coupled to Dynabeads 
(Invitrogen) and then 20min with anti-FLAG (M2, Sigma) Dynabeads. 
 
 
 
Apc15 Switch OFF 
The apc15 promotor was replaced by the nmt81 promotor. Cells were grown in PMGS –thiamine at 30oC for 24 
hours to ensure full expression of Apc15, then 15uM thiamine was added to repress transcription of Apc15. The 
cells were incubated for a further 2 hrs to ensure complete repression before inducing mitotic arrest using the 
cold sensitive nda3-KM311 mutation. Samples were taken every 2 hrs and snap frozen on dry ice for protein 
extraction and immunoblot analysis of Apc15 levels, or fixed in ice cold methanol for microscopy. Ability to 
arrest in mitosis was determined by Cdc13-GFP localisation.  
 
Apc15 antibodies 
Polyclonal anti-Apc15 antibodies were generated in sheep using 6xHis-Apc15 as antigen. These sera were 
affinity purified as described previously [S9] using Apc15-MBP coupled to Affigel 10 (Bio-Rad). 
 
 
 
 
List of fission yeast strains used in this study 
 
Figure 1 
JZ108 nda3-KM311 cdc13-GFP::leu2+ leu1-32 ura4D18      This lab 
KM905 nda3-KM311 cdc13-GFP::leu2 apc14∆::kanR leu1-32 ura4D18     This lab 
KM916 nda3-KM311 cdc13-GFP::leu2 apc15∆::kanR leu1-32 ura4D18    This lab 
VV1369 nda3-KM311 cdc13-GFP::leu2 mad2∆::kanR leu1-32 ura4D18    This lab 
KM936 nda3-KM311 cdc13-GFP::leu2 mad2∆::kanR apc15∆::kanR leu1-32 ura4D18    This lab 
 
KM910 nmt41Mph1::NAT leu1-32 ura4D18 
KM903 nmt41Mph1::NAT apc14∆::kanR leu1-32 ura4D18    This lab 
KM910 nmt41Mph1::NAT apc15∆::kanR leu1-32 ura4D18    This lab 
 
KP114 leu1-32 ura4D18 ade6-216        Allshire 
KM888  apc15∆::kanR leu1-32 ura4D18/ pRep1-Mad2   This lab 
 
OS18  cdc25-22 slp1-FLAG::hph mad3-GFP::his3+ leu1-32 ura4D18     This lab 
KM1218  cdc25-22 slp1-FLAG::hph mad3-GFP::his3+ mph1-kd::leu1+ leu1-32 ura4D18   This lab 
KM1220  cdc25-22 slp1-FLAG::hph mad3-GFP::his3+ apc15∆::NAT leu1-32 ura4D18    This lab 
KM1273  cdc25-22 slp1-FLAG::hph mad3-GFP::his3+  apc14∆::NAT leu1-32 ura4D18    This lab 
 
 
Figure 2 
MS304 cdc25-22 lid1-TAP::Kanr mad3-GFP::his3+  leu1-32 ura4D18     This lab 
YJZ917 cdc25-22 lid1-TAP::Kanr mad3-GFP::his3+ mph1-kd::leu1+ leu1-32 ura4D18    This lab 
KM896 cdc25-22 lid1-TAP::Kanr mad3-GFP::his3+ apc15∆::NAT leu1-32 ura4D18    This lab 
KM890 cdc25-22 lid1-TAP::Kanr mad3-GFP::his3+ apc14∆::NAT leu1-32 ura4D18    This lab 
 
VV1381 ark1-as3::hyg cdc13-gfp::leu nda3-KM11 leu1-32 ura4D18     This lab 
VV1403 ark1-as3::hyg cdc13-gfp::leu nda3-KM11 bub3::ura4+ leu1-32 ura4D18    This lab 
KM870 ark1-as3::hyg cdc13-gfp::leu nda3-KM11 apc14∆::kanR leu1-32 ura4D18    This lab 
 
VV54 nda3-KM311 leu1-32 ura4D18 
KM1160  nda3-KM311 apc1cut4-GFP::kanR leu1-32 ura4D18   This lab 
 
 
Figure 3 
KM1146  cdc25-22 slp1-FLAG::hph mad3-GFP::his3+ leu1-32 ura4D18     This lab 
 
KM1319 mts3-1 slp1-FLAG::hygR leu1-32 ura4D18   This lab 
KM1320 mts3-1 slp1-FLAG::hygR apc15∆::NAT leu1-32 ura4D18   This lab 
KM1321 mts3-1 slp1-FLAG::hygR apc14∆::NAT leu1-32 ura4D18   This lab 
KM1336 mts3-1 slp1-FLAG::hygR apc15∆::NAT mad3-KEN2-GFP::his3 leu1-32 ura4D18   This lab 
KM1344 mts3-1 slp1-FLAG::hygR apc15∆::NAT mad3∆::ura4 leu1-32 ura4D18   This lab 
KM1358 mts3-1 slp1-FLAG::hygR mad3∆::ura4 leu1-32 ura4D18   This lab 
KM1364 mts3-1 slp1-FLAG::hygR apc15∆::NAT mad3-KEN1-GFP::his3 leu1-32 ura4D18   This lab 
 
FP3 cdc25-22 slp1-HA::KanR ura4::slp1-FLAG::hygR mad3-GFP::his3+ leu1-32 ura4D18   This lab 
KM1313 cdc25-22 slp1-HA::KanR ura4::slp1-FLAG::hygR mad3∆::ura4 leu1-32 ura4D18   This lab 
KM1314 cdc25-22 slp1-HA::KanR ura4::slp1-FLAG::hygR mad3-KEN2-GFP::his3 leu1-32 ura4D18   This lab 
KM1315 cdc25-22 slp1-HA::KanR ura4::slp1-FLAG::hygR apc15∆::NAT mad3-GFP::his3+ leu1-32 ura4D18  This lab 
KM1316 cdc25-22 slp1-HA::KanR ura4::slp1-FLAG::hygR mad3-KEN1-GFP::his3 leu1-32 ura4D18 This lab 
 
Figure 4 
KM1465  cdc25-22 slp1-HA::KanR ura4::slp1-FLAG::hygR cut9apc6-GFP::kanR leu1-32 ura4D18 This lab 
KM1466  cdc25-22 slp1-HA::KanR ura4::slp1-FLAG::hygR cut9apc6-GFP::kanR apc15∆::NAT leu1-32 ura4D18 This lab 
 
Figure S2  
KM1179  nda3-KM311 cdc13-GFP::leu1 nat:nmt81-apc15-myc::kanR     This lab 
      
Figure S3 
KM1470 cdc25-22 mad3+ ura4D18        This lab 
KM1471 cdc25-22 mad3∆::ura4 leu1:: mad3-GFP ura4D18      This lab 
KM1472 cdc25-22 mad3+ leu1:: mad3-GFP ura4D18       This lab 
KM1473 cdc25-22 mad3+ leu1:: mad3-GFP apc15∆::NAT ura4D18     This lab 
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